SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000885590-23-000021
Filing Date
2023-05-17
Accepted
2023-05-17 08:16:20
Documents
12
Period of Report
2023-05-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20230517.htm   iXBRL 8-K 60879
  Complete submission text file 0000885590-23-000021.txt   202603

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20230517.xsd EX-101.SCH 1920
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20230517_lab.xml EX-101.LAB 25096
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20230517_pre.xml EX-101.PRE 13047
6 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20230517_htm.xml XML 11484
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 23929688
SIC: 2834 Pharmaceutical Preparations